These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11913529)

  • 21. Synthesis, structural evaluation, and estrogen receptor interaction of 2,3-diarylpiperazines.
    Gust R; Keilitz R; Schmidt K
    J Med Chem; 2002 May; 45(11):2325-37. PubMed ID: 12014971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
    Pettersson K; Delaunay F; Gustafsson JA
    Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human estrogen receptor bound to an estrogen response element bends DNA.
    Nardulli AM; Greene GL; Shapiro DJ
    Mol Endocrinol; 1993 Mar; 7(3):331-40. PubMed ID: 8483477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor.
    Al-Zaubai N; Johnstone CN; Leong MM; Li J; Rizzacasa M; Stewart AG
    J Pharmacol Exp Ther; 2014 Oct; 351(1):172-80. PubMed ID: 25077525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric modulation of estrogen receptor conformation by different estrogen response elements.
    Wood JR; Likhite VS; Loven MA; Nardulli AM
    Mol Endocrinol; 2001 Jul; 15(7):1114-26. PubMed ID: 11435612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
    Wilson VS; Bobseine K; Gray LE
    Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
    Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Veratrum nigrum inhibits the estrogenic activity of salvia miltiorrhiza bunge in vivo and in vitro.
    Xu Y; Chen T; Li X; Ya Kun Q; An JN; Zheng HX; Zhao Y; Zhang ZJ; Lin N
    Phytomedicine; 2018 Apr; 43():68-77. PubMed ID: 29747756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
    Tyulmenkov VV; Klinge CM
    Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA.
    Aliau S; Groblewski T; Borgna JL
    Eur J Biochem; 1995 Jul; 231(1):204-13. PubMed ID: 7628472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
    Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.